# Becton, Dickinson vs IDEXX Laboratories: stocks compared

URL: https://funkfolio.com/compare/bdx-vs-idxx

> Becton, Dickinson ($58.7B, P/E 42.6) and IDEXX Laboratories ($54.4B, P/E 46.5) compared: size, valuation, margins, debt, cash and price change.

---

## Becton, Dickinson vs IDEXX Laboratories

Becton, Dickinson (BDX), health care, and IDEXX Laboratories (IDXX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Becton, Dickinson is worth $58.7B on the stock market and IDEXX Laboratories $54.4B: Becton, Dickinson is valued at 8% more. Becton, Dickinson trades at 42.6 times earnings and IDEXX Laboratories at 46.5; operating margins in their latest fiscal years were 11.8% and 31.6%. Over the past year Becton, Dickinson's share price has moved +43.2% and IDEXX Laboratories's +4.54%.

### Key facts

- **Becton, Dickinson market value:** $58.7B
- **IDEXX Laboratories market value:** $54.4B
- **Becton, Dickinson P/E:** 42.6
- **IDEXX Laboratories P/E:** 46.5
- **Becton, Dickinson revenue:** $21.8B FY to 2025-09-30
- **IDEXX Laboratories revenue:** $4.3B FY to 2025-12-31
- **Superinvestors holding both:** 3

Market values as of 18 Nov 2026, 06:57 UTC.

Becton, Dickinson vs IDEXX Laboratories: every measure side by side

| Measure | Becton, Dickinson | IDEXX Laboratories |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-09-30 | 2025-12-31 |
| Size |  |  |
| Market cap | $58.7B higher | $54.4B lower |
| Revenue | $21.8B higher | $4.3B lower |
| Earnings | $1.7B higher | $1.1B lower |
| Employees | 60,000 higher | 11,000 lower |
| Total assets | $55.3B higher | $3.4B lower |
| Valuation |  |  |
| P/E | 42.6 lower | 46.5 higher |
| P/S | 2.7 lower | 12.6 higher |
| P/B | 2.4 lower | 29.1 higher |
| Dividend yield | 0.00% | 0.00% |
| Profitability |  |  |
| Operating margin | 11.8% lower | 31.6% higher |
| Balance sheet |  |  |
| Net assets | $25.4B higher | $1.6B lower |
| Total liabilities | $29.9B higher | $1.7B lower |
| Total debt | $19.2B higher | $450M lower |
| Cash on hand | $641M higher | $180.1M lower |
| Price change |  |  |
| Today | -0.49% higher | -1.49% lower |
| 1 year | +43.2% higher | +4.54% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Becton, Dickinson 143.5, IDEXX Laboratories 103.2.

- Becton, Dickinson (BDX)
- IDEXX Laboratories (IDXX)

Becton, Dickinson and IDEXX Laboratories share prices over one year, rebased to 100: Becton, Dickinson ends at 143.5, IDEXX Laboratories at 103.2.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | BDX | IDXX |
| --- | --- | --- |
| Nov 28, 2025 | 101.6 | 112.5 |
| Dec 31, 2025 | 101.6 | 101.1 |
| Jan 30, 2026 | 106.5 | 100.2 |
| Feb 27, 2026 | 117.5 | 98.2 |
| Mar 31, 2026 | 104.7 | 84.0 |
| Apr 30, 2026 | 99.3 | 83.8 |
| May 29, 2026 | 98.0 | 84.2 |
| Jun 30, 2026 | 100.8 | 78.7 |
| Jul 31, 2026 | 110.3 | 83.6 |
| Aug 31, 2026 | 125.3 | 83.2 |
| Sep 30, 2026 | 119.2 | 78.1 |
| Oct 30, 2026 | 131.8 | 82.4 |
| Nov 17, 2026 | 143.5 | 103.2 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (3)

- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) 0.5% / &lt;0.1%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) &lt;0.1% / &lt;0.1%
- [Jensen team](https://funkfolio.com/gurus/jensen-investment) &lt;0.1% / 1.8%

#### Becton, Dickinson only (8)

- [Edgar Wachenheim](https://funkfolio.com/gurus/edgar-wachenheim) 13.3%
- [Steven Romick](https://funkfolio.com/gurus/steven-romick) 4.6%
- [Matthew McLennan](https://funkfolio.com/gurus/first-eagle) 3.9%
- [Pat English](https://funkfolio.com/gurus/pat-english) 2.2%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 2.0%
- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.2%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.1%
- [Rajiv Jain](https://funkfolio.com/gurus/rajiv-jain) &lt;0.1%

#### IDEXX Laboratories only (7)

- [Terry Smith](https://funkfolio.com/gurus/terry-smith) 2.9%
- [Polen Capital team](https://funkfolio.com/gurus/polen-capital) 2.2%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 1.6%
- [Wallace Weitz](https://funkfolio.com/gurus/wallace-weitz) 1.3%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.2%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Becton, Dickinson / IDEXX Laboratories). [Who owns BDX](https://funkfolio.com/stock/BDX/superinvestors) · [Who owns IDXX](https://funkfolio.com/stock/IDXX/superinvestors)

### More on Becton, Dickinson

- [Becton, Dickinson (BDX) stock page](https://funkfolio.com/stock/BDX)
- [Becton, Dickinson market cap](https://funkfolio.com/stock/BDX/market-cap)
- [Becton, Dickinson revenue](https://funkfolio.com/stock/BDX/revenue)
- [Becton, Dickinson P/E ratio](https://funkfolio.com/stock/BDX/pe-ratio)
- [Becton, Dickinson operating margin](https://funkfolio.com/stock/BDX/operating-margin)
- [Becton, Dickinson total debt](https://funkfolio.com/stock/BDX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on IDEXX Laboratories

- [IDEXX Laboratories (IDXX) stock page](https://funkfolio.com/stock/IDXX)
- [IDEXX Laboratories market cap](https://funkfolio.com/stock/IDXX/market-cap)
- [IDEXX Laboratories revenue](https://funkfolio.com/stock/IDXX/revenue)
- [IDEXX Laboratories P/E ratio](https://funkfolio.com/stock/IDXX/pe-ratio)
- [IDEXX Laboratories operating margin](https://funkfolio.com/stock/IDXX/operating-margin)
- [IDEXX Laboratories total debt](https://funkfolio.com/stock/IDXX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Becton, Dickinson against its closest peers

- [Becton, Dickinson vs Edwards Lifesciences](https://funkfolio.com/compare/bdx-vs-ew)
- [Becton, Dickinson vs argenx](https://funkfolio.com/compare/argx-vs-bdx)
- [Becton, Dickinson vs Cardinal Health](https://funkfolio.com/compare/bdx-vs-cah)

#### IDEXX Laboratories against its closest peers

- [IDEXX Laboratories vs Medline](https://funkfolio.com/compare/idxx-vs-mdln)
- [IDEXX Laboratories vs Edwards Lifesciences](https://funkfolio.com/compare/ew-vs-idxx)
- [IDEXX Laboratories vs argenx](https://funkfolio.com/compare/argx-vs-idxx)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Becton, Dickinson or IDEXX Laboratories?**

By market value, Becton, Dickinson is the larger: $58.7B against $54.4B for IDEXX Laboratories. By revenue in its latest fiscal year, Becton, Dickinson is the larger: $21.8B against $4.3B for IDEXX Laboratories.

**Which has the higher P/E ratio?**

IDEXX Laboratories: 46.5, against 42.6 for Becton, Dickinson. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

IDEXX Laboratories: 31.6%, against 11.8% for Becton, Dickinson. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Becton, Dickinson: $19.2B, against $450M for IDEXX Laboratories. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Becton, Dickinson and IDEXX Laboratories?**

In their latest 13F filings, Bill Nygren, Mairs & Power team and Jensen team hold both.

### Cite this page

Funkfolio, “Becton, Dickinson vs IDEXX Laboratories”, data as of 18 November 2026. https://funkfolio.com/compare/bdx-vs-idxx

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
